Lazarus CDS leverages Artificial Intelligence to improve early cancer detection by turning a primary care doctor into a specialist for 5 minutes. For diseases like cervical cancer, this is as simple as a simple prompt that alerts physicians of high-risk patients, enabling them to make better clinical decisions. In skin cancer, we turn any mobile device into an AI-powered dermascope, automatically classifying risk based on a whole host of factors. Best of all, it's fully explainable. No black boxes, just real results.

Lazarus uses patient health data and AI to detect cancer early. The company has clinical decision support systems for skin and cervical cancer, which help improve the diagnostic accuracy of physicians.

Eon uses the most advanced form of AI to create layered Computational Linguistics (CL) data science models. CL understands text and the linguistic structure of English, similar to how the human brain reads. EPM eliminates the noise by extracting clinically relevant information from radiology reports, saves FTE time, and improves patient outcomes.

EPM is the first and only solution to identify incidental pulmonary nodules on Magnetic Resonance (MR), X-Ray, and Computed Tomography (CT) reports. This update allows facilities to capture approximately 25% more incidental pulmonary nodules.

Eon is a digital health that has created the industry's first Intelligent Care platform. Our advanced AI integrates with your EHR to identify incidental findings with 98% accuracy. From there, our technology risk-stratifies patients, creates clear care plans, and automates patient/provider outreach to increase adherence and outcomes.

The company now works with more than 900 hospitals, and has impacted 2 million patients.